Stocks and Investing
Stocks and Investing
Wed, March 4, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (TMDX) at Hold with Decreased Target to $16 on, Mar 4th, 2020
David Lewis of Morgan Stanley, Maintained "TransMedics Group, Inc." (TMDX) at Hold with Decreased Target from $22 to $16 on, Mar 4th, 2020.
David has made no other calls on TMDX in the last 4 months.
There is 1 other peer that has a rating on TMDX. Out of the 1 peers that are also analyzing TMDX, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Joshua Jennings of "Cowen & Co." Maintained at Buy with Decreased Target to $28 on, Thursday, November 7th, 2019